Development of effective immune response in adults with DS after Covid vaccine

The work shows the cellular and humoral responses to SARS-CoV-2 vaccination of 36 individuals with Down syndrome (DS) after one to three (V1) and six (V2) months.Source: Ainhoa Gutiérrez-Cobos, Diego Real de Asúa, Arantzazu Alfranca, et al.